Logo image of MOH

MOLINA HEALTHCARE INC (MOH) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:MOH - US60855R1005 - Common Stock

164.84 USD
+1.37 (+0.84%)
Last: 12/26/2025, 5:05:00 PM
164.68 USD
-0.16 (-0.1%)
After Hours: 12/26/2025, 5:05:00 PM
Fundamental Rating

5

Taking everything into account, MOH scores 5 out of 10 in our fundamental rating. MOH was compared to 102 industry peers in the Health Care Providers & Services industry. MOH has only an average score on both its financial health and profitability. MOH is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year MOH was profitable.
MOH had a negative operating cash flow in the past year.
In the past 5 years MOH has always been profitable.
In the past 5 years MOH always reported a positive cash flow from operatings.
MOH Yearly Net Income VS EBIT VS OCF VS FCFMOH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

1.2 Ratios

With a decent Return On Assets value of 5.62%, MOH is doing good in the industry, outperforming 79.41% of the companies in the same industry.
MOH has a Return On Equity of 21.07%. This is amongst the best in the industry. MOH outperforms 87.25% of its industry peers.
MOH's Return On Invested Capital of 11.98% is amongst the best of the industry. MOH outperforms 86.27% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MOH is significantly above the industry average of 9.61%.
The last Return On Invested Capital (11.98%) for MOH is well below the 3 year average (17.96%), which needs to be investigated, but indicates that MOH had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.62%
ROE 21.07%
ROIC 11.98%
ROA(3y)7.1%
ROA(5y)6.75%
ROE(3y)26.28%
ROE(5y)27.2%
ROIC(3y)17.96%
ROIC(5y)17.65%
MOH Yearly ROA, ROE, ROICMOH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

MOH has a better Profit Margin (1.98%) than 60.78% of its industry peers.
MOH's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 2.97%, MOH perfoms like the industry average, outperforming 54.90% of the companies in the same industry.
MOH's Operating Margin has declined in the last couple of years.
MOH has a worse Gross Margin (13.91%) than 67.65% of its industry peers.
In the last couple of years the Gross Margin of MOH has declined.
Industry RankSector Rank
OM 2.97%
PM (TTM) 1.98%
GM 13.91%
OM growth 3Y1.53%
OM growth 5Y-7.6%
PM growth 3Y6.92%
PM growth 5Y-7.91%
GM growth 3Y1.48%
GM growth 5Y-2.5%
MOH Yearly Profit, Operating, Gross MarginsMOH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

5

2. Health

2.1 Basic Checks

MOH has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, MOH has less shares outstanding
Compared to 5 years ago, MOH has less shares outstanding
MOH has a worse debt/assets ratio than last year.
MOH Yearly Shares OutstandingMOH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MOH Yearly Total Debt VS Total AssetsMOH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 4.28 indicates that MOH is not in any danger for bankruptcy at the moment.
The Altman-Z score of MOH (4.28) is better than 77.45% of its industry peers.
A Debt/Equity ratio of 0.92 indicates that MOH is somewhat dependend on debt financing.
MOH has a Debt to Equity ratio of 0.92. This is comparable to the rest of the industry: MOH outperforms 40.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Altman-Z 4.28
ROIC/WACC1.43
WACC8.36%
MOH Yearly LT Debt VS Equity VS FCFMOH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.68 indicates that MOH should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.68, MOH is doing good in the industry, outperforming 63.73% of the companies in the same industry.
MOH has a Quick Ratio of 1.68. This is a normal value and indicates that MOH is financially healthy and should not expect problems in meeting its short term obligations.
MOH has a Quick ratio of 1.68. This is in the better half of the industry: MOH outperforms 68.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1.68
MOH Yearly Current Assets VS Current LiabilitesMOH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

The earnings per share for MOH have decreased strongly by -16.06% in the last year.
MOH shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.16% yearly.
MOH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.65%.
Measured over the past years, MOH shows a quite strong growth in Revenue. The Revenue has been growing by 19.29% on average per year.
EPS 1Y (TTM)-16.06%
EPS 3Y18.68%
EPS 5Y14.16%
EPS Q2Q%-69.38%
Revenue 1Y (TTM)13.65%
Revenue growth 3Y13.54%
Revenue growth 5Y19.29%
Sales Q2Q%11%

3.2 Future

Based on estimates for the next years, MOH will show a small growth in Earnings Per Share. The EPS will grow by 4.82% on average per year.
MOH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.46% yearly.
EPS Next Y-36.41%
EPS Next 2Y-22.61%
EPS Next 3Y-9.96%
EPS Next 5Y4.82%
Revenue Next Year10.73%
Revenue Next 2Y7.54%
Revenue Next 3Y7.33%
Revenue Next 5Y5.46%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MOH Yearly Revenue VS EstimatesMOH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
MOH Yearly EPS VS EstimatesMOH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 10 20

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 8.93 indicates a reasonable valuation of MOH.
Based on the Price/Earnings ratio, MOH is valued cheaper than 94.12% of the companies in the same industry.
MOH's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.59.
The Price/Forward Earnings ratio is 12.15, which indicates a correct valuation of MOH.
MOH's Price/Forward Earnings ratio is rather cheap when compared to the industry. MOH is cheaper than 85.29% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.03, MOH is valued a bit cheaper.
Industry RankSector Rank
PE 8.93
Fwd PE 12.15
MOH Price Earnings VS Forward Price EarningsMOH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.27
MOH Per share dataMOH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 400 600 800

4.3 Compensation for Growth

The decent profitability rating of MOH may justify a higher PE ratio.
MOH's earnings are expected to decrease with -9.96% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.63
EPS Next 2Y-22.61%
EPS Next 3Y-9.96%

0

5. Dividend

5.1 Amount

MOH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

MOLINA HEALTHCARE INC

NYSE:MOH (12/26/2025, 5:05:00 PM)

After market: 164.68 -0.16 (-0.1%)

164.84

+1.37 (+0.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-22 2025-10-22/amc
Earnings (Next)02-03 2026-02-03/amc
Inst Owners113.09%
Inst Owner Change12.27%
Ins Owners1.33%
Ins Owner Change1.12%
Market Cap8.47B
Revenue(TTM)44.55B
Net Income(TTM)883.00M
Analysts56.3
Price TargetN/A
Short Float %8.65%
Short Ratio2.48
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-29.8%
Min EPS beat(2)-53.34%
Max EPS beat(2)-6.27%
EPS beat(4)1
Avg EPS beat(4)-17.79%
Min EPS beat(4)-53.34%
Max EPS beat(4)1.06%
EPS beat(8)4
Avg EPS beat(8)-7.75%
EPS beat(12)8
Avg EPS beat(12)-3.04%
EPS beat(16)12
Avg EPS beat(16)-1.32%
Revenue beat(2)2
Avg Revenue beat(2)3.64%
Min Revenue beat(2)3.29%
Max Revenue beat(2)3.99%
Revenue beat(4)4
Avg Revenue beat(4)2.53%
Min Revenue beat(4)0.69%
Max Revenue beat(4)3.99%
Revenue beat(8)8
Avg Revenue beat(8)3.12%
Revenue beat(12)10
Avg Revenue beat(12)2.26%
Revenue beat(16)14
Avg Revenue beat(16)2.23%
PT rev (1m)-8.49%
PT rev (3m)-16.77%
EPS NQ rev (1m)-45.19%
EPS NQ rev (3m)-84.91%
EPS NY rev (1m)-4.2%
EPS NY rev (3m)-25.1%
Revenue NQ rev (1m)0.16%
Revenue NQ rev (3m)-0.89%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)0.67%
Valuation
Industry RankSector Rank
PE 8.93
Fwd PE 12.15
P/S 0.19
P/FCF N/A
P/OCF N/A
P/B 2.02
P/tB 4.26
EV/EBITDA -0.27
EPS(TTM)18.45
EY11.19%
EPS(NY)13.57
Fwd EY8.23%
FCF(TTM)-11.17
FCFYN/A
OCF(TTM)-8.97
OCFYN/A
SpS866.73
BVpS81.54
TBVpS38.7
PEG (NY)N/A
PEG (5Y)0.63
Graham Number183.98
Profitability
Industry RankSector Rank
ROA 5.62%
ROE 21.07%
ROCE 16.11%
ROIC 11.98%
ROICexc N/A
ROICexgc N/A
OM 2.97%
PM (TTM) 1.98%
GM 13.91%
FCFM N/A
ROA(3y)7.1%
ROA(5y)6.75%
ROE(3y)26.28%
ROE(5y)27.2%
ROIC(3y)17.96%
ROIC(5y)17.65%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)24.15%
ROCE(5y)23.74%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y1.53%
OM growth 5Y-7.6%
PM growth 3Y6.92%
PM growth 5Y-7.91%
GM growth 3Y1.48%
GM growth 5Y-2.5%
F-Score4
Asset Turnover2.84
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Debt/EBITDA 2.53
Cap/Depr 56.78%
Cap/Sales 0.25%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.68
Quick Ratio 1.68
Altman-Z 4.28
F-Score4
WACC8.36%
ROIC/WACC1.43
Cap/Depr(3y)51.53%
Cap/Depr(5y)59.49%
Cap/Sales(3y)0.26%
Cap/Sales(5y)0.29%
Profit Quality(3y)92.3%
Profit Quality(5y)171.56%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.06%
EPS 3Y18.68%
EPS 5Y14.16%
EPS Q2Q%-69.38%
EPS Next Y-36.41%
EPS Next 2Y-22.61%
EPS Next 3Y-9.96%
EPS Next 5Y4.82%
Revenue 1Y (TTM)13.65%
Revenue growth 3Y13.54%
Revenue growth 5Y19.29%
Sales Q2Q%11%
Revenue Next Year10.73%
Revenue Next 2Y7.54%
Revenue Next 3Y7.33%
Revenue Next 5Y5.46%
EBIT growth 1Y-19.56%
EBIT growth 3Y15.28%
EBIT growth 5Y10.22%
EBIT Next Year-31.67%
EBIT Next 3Y-9.72%
EBIT Next 5YN/A
FCF growth 1Y-128.12%
FCF growth 3Y-35.66%
FCF growth 5Y7.61%
OCF growth 1Y-121.54%
OCF growth 3Y-32.77%
OCF growth 5Y8.21%

MOLINA HEALTHCARE INC / MOH FAQ

What is the fundamental rating for MOH stock?

ChartMill assigns a fundamental rating of 5 / 10 to MOH.


Can you provide the valuation status for MOLINA HEALTHCARE INC?

ChartMill assigns a valuation rating of 4 / 10 to MOLINA HEALTHCARE INC (MOH). This can be considered as Fairly Valued.


How profitable is MOLINA HEALTHCARE INC (MOH) stock?

MOLINA HEALTHCARE INC (MOH) has a profitability rating of 6 / 10.


What is the financial health of MOLINA HEALTHCARE INC (MOH) stock?

The financial health rating of MOLINA HEALTHCARE INC (MOH) is 5 / 10.


What is the earnings growth outlook for MOLINA HEALTHCARE INC?

The Earnings per Share (EPS) of MOLINA HEALTHCARE INC (MOH) is expected to decline by -36.41% in the next year.